
the staff of the Ridgewood blog
Ridgewood NJ, , a diverse group of New Jersey patient, healthcare, and employer advocates opposed Governor Murphy’s proposal to include significant fees on pharmaceutical manufacturers and wholesale distributors in the Fiscal Year 2021 State Budget. These groups — including the American Cancer Society of New Jersey Cancer Action Network, Home Care & Hospice Association of New Jersey, the New Jersey Pharmacists Association, the New Jersey Council of Chain Drug Stores, New Jersey Business and Industry Association, and the Chamber of Commerce Southern New Jersey — cite serious concerns that such substantial fees would harm patients and increase healthcare costs.
Continue reading Patient Advocates Warn of Murphy’s Plan to Raise the Price of Medicines in FY 2021 Budget Proposal